Our study adds a new dimension to this theme by demonstrating that Cosmc dysfunction in colonic cancer is sufficient to induce aberrant O‐glycosylation and consequently promotes oncogenic features, thereby supporting that aberrant O‐glycosylation contributes to the progression of CRC. This evidence concerns the gene C1GALT1C1 and colorectal carcinoma.